In December a deal was reached – under Dr. Anothny Fauci, left – between Moderna and the NIH, Dartmouth, and Scipps Research, so the drugmaker would pay “royalties” to the scientist that developed the techniques used to make the Moderna COVID vaccine. (Saul Loeb – AFP / Getty images ; OsakaWayne Studios / Getty Images)
Drugmaker Moderna last week announced it had paid out $400 million to settle a dispute over the company’s use of federally funded research at two universities that led to the development of a technique used in its coronavirus vaccine.
The so-called “royalties” will go to the National Institutes of Health, as well as Dartmouth and Scripps Research, where the technique was developed, according to The New York Times.
“If pharmaceutical companies are going to make billions of dollars, it seems reasonable that the scientists who helped generate some of the initial intellectual property and the universities also share some of the gains,” said Jason McLellan, a structural biologist who in 2017 led the team at the Geisel School of Medicine at Dartmouth that developed the technique. Read More>>>>